July 31, 2022

Brand Medications with Generic Alternatives Anticipated to be Approved in August

Read More
July 19, 2022

FDA Approves First Therapy for Repigmentation in Vitiligo

Read More
July 15, 2022

Zonisade Approved to Treat Seizures

Read More
July 14, 2022

Xalkori Granted New Indication to Treat Non-Cancerous Tumors

Read More
July 14, 2022

Diacomit Approved for Broader Age Group

Read More
July 8, 2022

Krystexxa Approved for Use with Methotrexate

Read More
July 8, 2022

Comirnaty Receives Full FDA Approval for Expanded Age Group

Read More
July 6, 2022

Mylan Recalls One Lot of Insulin Glargine

Read More
July 6, 2022

Pharmacists Now Able to Prescribe Paxlovid

Read More
July 1, 2022

Brand Medications with Generic Alternatives Anticipated to be Approved in July

Read More
June 30, 2022

Copiktra May Increase Risk for Cancer Patients

Read More
June 30, 2022

Zelnorm Withdrawn from Market

Read More